Diffusing Capacity For Carbon Monoxide

Diffusing Capacity for Carbon Monoxide (DLCO), also known as Carbon Monoxide Lung Diffusion Capacity, is a clinical test that measures the ability of the lungs to transfer gas from inhaled air to the red blood cells in pulmonary capillaries. It is an important diagnostic tool used to assess the gas exchange function of the lungs. This test is particularly useful in diagnosing and managing conditions that affect pulmonary gas exchange, including pulmonary fibrosis, emphysema, and pulmonary hypertension.

Overview

The DLCO test involves the patient inhaling a small amount of carbon monoxide (CO) for a very short time, usually just a single breath. Carbon monoxide is used because it binds to hemoglobin with a much greater affinity than oxygen, making it an effective tracer gas for measuring gas exchange. The concentration of CO in the exhaled breath is then measured. The difference in the inhaled and exhaled CO concentrations allows clinicians to calculate the volume of gas that has been transferred from the lungs to the blood.

Physiology

The ability of the lungs to transfer gas is influenced by several factors, including the surface area of the alveoli, the thickness of the alveolar-capillary membrane, and the volume of blood passing through the capillaries. A decrease in DLCO can indicate a problem with any of these factors. For example, a reduction in alveolar surface area, as seen in emphysema, or an increase in the thickness of the alveolar-capillary membrane, as seen in pulmonary fibrosis, can lead to a decreased DLCO.

Indications

DLCO testing is indicated for the evaluation of patients with unexplained dyspnea (shortness of breath), and for the diagnosis and management of various lung diseases, including:

• Pulmonary fibrosis
• Emphysema
• Pulmonary hypertension
• Chronic obstructive pulmonary disease (COPD)

Procedure

The DLCO test is performed using a spirometer equipped with a gas analyzer. The patient is instructed to breathe in a gas mixture containing a very small amount of CO, usually less than 0.3%. After holding their breath for about 10 seconds, the patient then exhales. The first part of the exhaled breath, which represents dead space air, is discarded, and the concentration of CO in the alveolar sample is measured.

Interpretation

The results of the DLCO test are usually reported in milliliters per minute per millimeter of mercury (mL/min/mmHg). The normal range for DLCO varies depending on age, sex, hemoglobin levels, and lung volume. Results are typically adjusted for hemoglobin concentration and, in some cases, for lung volume. A decreased DLCO value indicates impaired gas exchange, while an increased DLCO can be seen in conditions such as polycythemia or left-to-right cardiac shunts.

Limitations

The DLCO test has several limitations. It is affected by the patient's effort and technique, making proper instruction and supervision crucial. It is also influenced by hemoglobin levels, altitude, and smoking status. Furthermore, DLCO cannot pinpoint the exact cause of the abnormal gas exchange, necessitating further diagnostic testing in many cases.

Conclusion

The DLCO test is a valuable tool in the diagnosis and management of diseases affecting the pulmonary vasculature and the alveolar-capillary membrane. It provides critical information about the lung's ability to transfer gas from inhaled air to the bloodstream, which is essential for effective oxygenation of the body.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian